Provided by Tiger Trade Technology Pte. Ltd.

Apogee Therapeutics

134.75
0.0000
Post-market: 134.750.00000.00%19:30 EDT
Volume:948.28K
Turnover:127.82M
Market Cap:10.15B
PE:-31.05
High:134.82
Open:134.79
Low:134.70
Close:134.75
52wk High:134.88
52wk Low:35.39
Shares:75.34M
Float Shares:58.14M
Volume Ratio:0.68
T/O Rate:1.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3400
EPS(LYR):-4.2155
ROE:-32.46%
ROA:-20.30%
PB:8.50
PE(LYR):-31.97

Loading ...

AbbVie Closes USD 10B Multi-Tranche Senior Notes Offering to Fund Apogee Deal

Reuters
·
Aug 19

Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE) and Biogen (BIIB)

TIPRANKS
·
Aug 14

U.S. Research Roundup-Airbnb, Five Below, Silgan Holdings

Reuters
·
Aug 13

BTIG Downgrades Apogee Therapeutics to Neutral From Buy

MT Newswires Live
·
Aug 12

Apogee Therapeutics, Inc. : Btig Cuts to Neutral from Buy

THOMSON REUTERS
·
Aug 12

Apogee Therapeutics Cut to Neutral from Buy by BTIG

Dow Jones
·
Aug 12

RBC Capital Sticks to Their Hold Rating for Apogee Therapeutics (APGE)

TIPRANKS
·
Aug 12

Apogee Therapeutics Gelar Rapat Khusus Pemegang Saham Lewat Webcast Langsung

Reuters
·
Aug 12

Analysts Offer Insights on Healthcare Companies: Relmada Therapeutics (RLMD), Surgery Partners (SGRY) and Apogee Therapeutics (APGE)

TIPRANKS
·
Aug 12

Wedbush Reaffirms Their Hold Rating on Apogee Therapeutics (APGE)

TIPRANKS
·
Aug 11

Apogee Therapeutics’ Merger Faces Significant Execution Risks, Potential $381 Million Termination Fee and Stock Price Pressure

TIPRANKS
·
Aug 11

Apogee Therapeutics Q2 EPS $(1.14) Misses $(1.05) Estimate

Benzinga Earnings
·
Aug 10

Earnings Flash (APGE) Apogee Therapeutics Posts Q2 Net Loss $85.9M, vs. FactSet Est of $78.7M Loss

MT Newswires Live
·
Aug 10

Apogee Net Loss Widens to $85.85 Million in Q2 FY26; R&D Expenses Rise to $67.3 Million

Reuters
·
Aug 10

Apogee Reports Second Quarter 2026 Financial Results and Recent Corporate and Pipeline Updates

THOMSON REUTERS
·
Aug 10

Apogee Therapeutics, - Q2 2026 Net Loss $85.90 Mln

THOMSON REUTERS
·
Aug 10

Apogee Therapeutics CMO Carl Dambkowski Disposes of USD 737,935 in Common Shares

Reuters
·
Aug 08

Market Chatter: AbbVie Launches $10 Billion Bond Sale to Fund Apogee Acquisition

MT Newswires Live
·
Aug 05

Abbvie Seeks at Least $8 Billion in Debt to Fund Apogee Deal - Bloomberg News

THOMSON REUTERS
·
Aug 04

Abbvie : Plans to Use Note Offering Proceeds for Apogee Therapeutics Acquisition Funding

THOMSON REUTERS
·
Aug 04